Here you can find all scientific publications about LAKANA and its´ substudies

• Luoma J, Adubra L, Alber D, Ashorn P, Ashorn U, Cloutman-Green E, et al. Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali. Trials. 2023 Nov 15;24:733.

• Adubra L, Alber D, Ashorn P, Ashorn U, Cheung YB, Cloutman-Green E, Diallo F, Ducker C, Elovainio R, Fan YM, Gates L, Gruffudd G, Haapaniemi T, Haidara F, Hallamaa L, Ihamuotila R, Klein N, Luoma J, Martell O, Sow S, Vehmasto T and LAKANA Trial team 2023. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11 -month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, paraller-group, three-arm clinical trial. Trials (2023) 24:5

• Alber D, Haidara FD, Luoma J, Adubra L, Ashorn P, Ashorn U, Badji H, Cloutman-Green E, Diallo F, Ihamuotila R, Klein N, Martell O, Onwuckhekwa U, Oumar S, Sow S, Traore A, Wilson K, Ducker C and Fan YM. 2022. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021. BMJ Open 2022. [LAKANA-COVID substudy]